Skip to main content
Clinical Trials/NCT01006811
NCT01006811
Completed
Phase 2

Efficacy and Tolerability of the Modified Atkins Diet in Patients With Infantile Spasms: a Pilot Study.

All India Institute of Medical Sciences, New Delhi1 site in 1 country15 target enrollmentOctober 2009

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Infantile Spasms
Sponsor
All India Institute of Medical Sciences, New Delhi
Enrollment
15
Locations
1
Primary Endpoint
seizure reduction as per parental reports
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

Infantile spasms constitute a type of catastrophic epilepsy syndrome occuring in young children. The ketogenic diet has been shown to be very effective in these children. The modified Atkins diet is a less restrictive option than the ketogenic diet, which has been effective in preliminary studies on refractory epilepsy in children, adolescents and adults. Modified Atkins diet may be of special importance in infants, as proteins are not restricted, hence no problems with growth are expected. Hence this pilot study has been planned to evaluate the efficacy and tolerability of the modified Atkins diet in infantile spasms refractory to conventional treatment (ACTH, vigabatrin, and anti-epileptic drugs).

Registry
clinicaltrials.gov
Start Date
October 2009
End Date
November 2010
Last Updated
15 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
All India Institute of Medical Sciences, New Delhi

Eligibility Criteria

Inclusion Criteria

  • Age: 6 months to 3 years.
  • Presence of epileptic spasms in clusters, with electroencephalographic evidence of hypsarrhythmia or its variants), having at least one cluster per day.
  • Treatment with at least corticosteroid/ ACTH or Vigabatrin and one other AED( sodium valproate, pyridoxine, topiramate, zonisamide, benzodiazepines (clobazam, clonazepam, nitrazepam).

Exclusion Criteria

  • Known or suspected inborn error of metabolism, as evidenced by: Clinical suspicion of metabolic disorder as evidenced by 2 or more of the following- a history of parental consanguinity, prior affected siblings, unexplained vomiting, intermittent worsening of symptoms, recurrent episodes of lethargy, altered sensorium, or ataxia, hepatosplenomegaly on examination And/ or 2 or more of the following biochemical abnormalities High blood ammonia (\>80mmol/L), High arterial lactate (\>2 mmol/L), metabolic acidosis (pH \<7.2), hypoglycaemia (blood sugar \<40 mg/dl), abnormal urinary aminoacidogram, presence of reducing sugars or ketones in urine, and positive results on urine neurometabolic screening tests.
  • Motivational or psychosocial issues in the family which would preclude compliance
  • Systemic illness- chronic hepatic, cardiac, renal or pulmonary disease

Outcomes

Primary Outcomes

seizure reduction as per parental reports

Time Frame: 3 months

seizure control at the end of 3 months will be classified as: spasm free; \> 50% reduction in spasms; and \< 50% reduction in spasms

Secondary Outcomes

  • adverse effects of the diet as per parental reports(3 months)

Study Sites (1)

Loading locations...

Similar Trials